Andrew D.c. LaFrence, Chief Financial Officer at Vyant Bio, Inc. (VYNT), bought 5,000 shares at $2.00 ($10K) on 2021-11-23, disclosed to the SEC on 2021-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.